AGP Executive Report
Last update: 4 hours agoFederal Cannabis Policy: A U.S. Senate committee urged the VA to study medical marijuana as a possible opioid alternative for veterans, backed research into psychedelics and flagged concerns about cannabinoid-infused foods. Hemp Product Safety: A Pennsylvania sheriff warned that intoxicating hemp-derived gummies, vapes and drinks can reach children through shops and online, often without consistent testing, labeling or age limits. Brazilian Market: MediPharm Labs launched sales of an ANVISA-authorized cannabis extract oil in Brazil, expanding its international business. Patient Access: A reported freeze on South Africa’s Section 21 cannabis approvals is raising concerns about access for vulnerable patients. CBD Labeling: The EU’s top court ruled that CBD products cannot be labeled organic. Lebanon’s Farmers: Six years after Lebanon legalized cannabis cultivation for medical and industrial use, farmers say missing regulations still leave many growing outside the law.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.